NewsRx Logo Login/Signup
Home Newsletters Products Library About Us Contact -- Search NewsRx

NewsRx | Free Trials
Advertisement
VerticalNews | Global Warming
Advertisement
NewsRx | Free Trials
Advertisement
----------
------------
NewsRx on Facebook
-----
Press Release Submissions
PR Login
*
*

Thyroid Disease


Study results from A.L.V. Barcelos et al provide new insights into dyslipidemias



NewsRx
Thyroid Disease Library
Library Home

This article was published in Diabetes Week, which you can subscribe to online.

NewsRx
NewsRx
2009 JUL 20 - (NewsRx.com) -- According to recent research published in the Brazilian Journal of Medical and Biological Research, "We investigated the effect of the -278A >C polymorphism in the CYP7A1 gene on the response of plasma lipids to a reduced-fat diet for 6 to 8 weeks in a group of 82 dyslipidemic males with a mean age of 46.0 +/- 11.7 years. Individuals who presented at least one high alteration in total cholesterol, low-density lipoprotein cholesterol or triglyceride values were considered to be dyslipidemic."

"Exclusion criteria were secondary dyslipidemia due to diabetes mellitus, renal, liver, or thyroid disease. None of the subjects were using lipid-lowering medication. Baseline and follow-up lipid concentrations were measured. The genotypes were determined by the digestion of PCR products with the BsaI restriction endonuclease. There were statistically significant reductions in plasma total cholesterol, low-density lipoprotein cholesterol and triglyceride concentrations after dietary intervention. The minor allele C has a frequency of 43%. Carriers of the C allele had significantly lower triglyceride concentrations (P = 0.02) than AA homozygotes. After adjustment of covariates, subjects with the AC and CC genotypes showed a greater reduction in triglyceride concentrations compared to subjects with the AA genotype. Multiple linear regression analyses showed that the AC and CC CYP7A1 genotypes accounted for 5.2 and 6.2% of triglyceride concentration during follow-up and adjusted percent of change of triglyceride concentration, respectively. The present study provides evidence that -278A >C polymorphism in the CYP7A1 gene can modify triglyceride concentrations in response to a reduced fat diet in a dyslipidemic male population," wrote A.L.V. Barcelos and colleagues.

The researchers concluded: "This gene represents a potential locus for a nutrigenetic directed approach."

Barcelos and colleagues published their study in Brazilian Journal of Medical and Biological Research (Association of CYP7A1-278A>C polymorphism and the response of plasma triglyceride after dietary intervention in dyslipidemic patients. Brazilian Journal of Medical and Biological Research, 2009;42(6):487-493).

For additional information, contact C.M.D. Silva, Fundacao Estadual Prod & Pesquisa Saude, Center Desenvolvimento Cient & Tecnol, Av Ipiranga 5400, BR-90610000 Porto Alegre, RS, Brazil.

The publisher's contact information for the Brazilian Journal of Medical and Biological Research is: Association Bras Divulg Cientifica, Faculdade Medicina, Sala 21, 14049 Ribeirao Preto, Sao Paulo, Brazil.

Keywords: Brazil, Porto Alegre, Diabetes, Diabetes Mellitus, Digestion, Dyslipidemias, Endocrinology, Endonucleases, Enzyme Research, Enzymology, Gastroenterology, Genotyping, Kidney, Nephrology, Thyroid Disease.

This article was prepared by Diabetes Week editors from staff and other reports. Copyright 2009, Diabetes Week via NewsRx.com.

NewsRx Passes
Advertisement
------------------------
Security by Verisign PR Login